[
    {
        "title": "Oncolytic viruses in cancer treatment: a review",
        "link": "https://jamanetwork.com/journals/jamaoncology/article-abstract/2536204",
        "authors": "SE Lawler, MC Speranza, CF Cho, EA Chiocca\u00a0- JAMA oncology, 2017 - jamanetwork.com",
        "abstract": "\u2026 of Action of Oncolytic Viruses. It is thought that most oncolytic viruses function through a \u2026 \ninnate and adaptive immunity through presentation of viral and tumor antigens. DAMPs indicates \u2026"
    },
    {
        "title": "Oncolytic viruses",
        "link": "https://www.nature.com/articles/nrc948",
        "authors": "E Antonio Chiocca\u00a0- Nature Reviews Cancer, 2002 - nature.com",
        "abstract": "\u2026 of oncolytic viral research are to increase tumour selectivity by modifying the viral genome, to \ncombine oncolytic viral \u2026 , and to 'arm' the viruses with suicide cDNAs and/or cytokine cDNAs \u2026"
    },
    {
        "title": "Therapy with oncolytic viruses: progress and challenges",
        "link": "https://www.nature.com/articles/s41571-022-00719-w",
        "authors": "SZ Shalhout, DM Miller, KS Emerick\u2026\u00a0- Nature reviews Clinical\u00a0\u2026, 2023 - nature.com",
        "abstract": "\u2026 Oncolytic viruses (OVs) are an emerging class of cancer therapeutics that offer the benefits \n\u2026 To date, four OVs and one non-oncolytic virus have been approved for the treatment of \u2026"
    },
    {
        "title": "[HTML][HTML] Oncolytic viruses: a new class of immunotherapy drugs",
        "link": "https://www.nature.com/articles/nrd4663",
        "authors": "HL Kaufman, FJ Kohlhapp, A Zloza\u00a0- Nature reviews Drug discovery, 2015 - nature.com",
        "abstract": "\u2026 issues in the development of oncolytic virus immunotherapy. We discuss preclinical and \u2026 \noncolytic viruses in cancer therapy and detail some of the unique challenges in oncolytic viruse \u2026"
    },
    {
        "title": "[HTML][HTML] Oncolytic viruses: adenoviruses",
        "link": "https://link.springer.com/article/10.1007/s11262-017-1488-1",
        "authors": "J Niemann, F K\u00fchnel\u00a0- Virus Genes, 2017 - Springer",
        "abstract": "\u2026 With a focus on oncolytic adenoviruses, we will describe the efforts to restrict oncolytic virus \n\u2026 Furthermore, we will discuss ways to optimize virus-mediated immunostimulation and the \u2026"
    },
    {
        "title": "[HTML][HTML] Oncolytic viruses for cancer immunotherapy",
        "link": "https://link.springer.com/article/10.1186/s13045-020-00922-1",
        "authors": "O Hemminki, JM Dos Santos, A Hemminki\u00a0- Journal of hematology &\u00a0\u2026, 2020 - Springer",
        "abstract": "\u2026 of oncolytic viruses in cancer immunotherapy treatments in general, with a particular focus on \nadenoviruses. These serve as a model to elucidate how versatile viruses \u2026 oncolytic viruses. \u2026"
    },
    {
        "title": "Oncolytic viruses in cancer therapy",
        "link": "https://www.sciencedirect.com/science/article/pii/S0304383507000468",
        "authors": "MJV V\u00e4h\u00e4-Koskela, JE Heikkil\u00e4, AE Hinkkanen\u00a0- Cancer letters, 2007 - Elsevier",
        "abstract": "\u2026 We have strived to acknowledge as many different oncolytic viruses as \u2026 viruses. Some of \nthe newest additions to the panel of oncolytic viruses include the avian adenovirus, foamy virus, \u2026"
    },
    {
        "title": "[HTML][HTML] Oncolytic viruses: finally delivering",
        "link": "https://www.nature.com/articles/bjc2015481",
        "authors": "LW Seymour, KD Fisher\u00a0- British journal of cancer, 2016 - nature.com",
        "abstract": "\u2026 Oncolytic viruses can be found at the confluence of virology, genetic engineering and \u2026 \nOncolytic viruses offer several important advantages over traditional approaches, including \u2026"
    },
    {
        "title": "[HTML][HTML] History of oncolytic viruses: genesis to genetic engineering",
        "link": "https://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(16)31331-4",
        "authors": "E Kelly, SJ Russell\u00a0- Molecular therapy, 2007 - cell.com",
        "abstract": "\u2026 For more than a hundred years, viruses have been pursued as experimental agents of \u2026 an \noncolytic virus, granted by Chinese regulators for the genetically modified oncolytic adenovirus \u2026"
    },
    {
        "title": "Oncolytic viruses and their application to cancer immunotherapy",
        "link": "https://aacrjournals.org/cancerimmunolres/article-abstract/2/4/295/467170",
        "authors": "EA Chiocca, SD Rabkin\u00a0- Cancer immunology research, 2014 - AACR",
        "abstract": "\u2026 Oncolytic Viruses Oncolytic virus (OV) therapy is based on selective replication of viruses \nin cancer cells and their subsequent spread within a tumor without causing damage to normal \u2026"
    },
    {
        "title": "Integrating oncolytic viruses in combination cancer immunotherapy",
        "link": "https://www.nature.com/articles/s41577-018-0014-6",
        "authors": "PK Bommareddy, M Shettigar\u2026\u00a0- Nature Reviews\u00a0\u2026, 2018 - nature.com",
        "abstract": "\u2026 Furthermore, we discuss how the therapeutic efficacy of oncolytic viruses depends on the \nbalance between antiviral and antitumour immunity and explore how oncolytic viruses are well \u2026"
    },
    {
        "title": "[HTML][HTML] Clinical landscape of oncolytic virus research in 2020",
        "link": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552841/",
        "authors": "N Macedo, DM Miller, R Haq\u2026\u00a0- \u2026\u00a0for immunotherapy of\u00a0\u2026, 2020 - ncbi.nlm.nih.gov",
        "abstract": "\u2026 for keywords \u201concolytic virus\u201d and \u201concolytic viruses\u201d. \u2026 of virus used, the nature of the viral \nbackbone (ie, native virus, modified or recombinant virus, or activation of latent intracellular virus\u2026"
    },
    {
        "title": "Designing and building oncolytic viruses",
        "link": "https://www.tandfonline.com/doi/abs/10.2217/fvl-2016-0129",
        "authors": "J Maroun, M Mu\u00f1oz-Al\u00eda, A Ammayappan\u2026\u00a0- Future\u00a0\u2026, 2017 - Taylor & Francis",
        "abstract": "Oncolytic viruses (OVs) are engineered and/or \u2026 virus engineering strategies that are being \npursued to optimize delivery, intratumoral spread and safety of OVs derived from different virus \u2026"
    },
    {
        "title": "[HTML][HTML] Clinical application of oncolytic viruses: a systematic review",
        "link": "https://www.mdpi.com/1422-0067/21/20/7505",
        "authors": "M Cook, A Chauhan\u00a0- International journal of molecular sciences, 2020 - mdpi.com",
        "abstract": "\u2026 We present the most comprehensive systematic review of all oncolytic viruses in Phase 1, 2, \n\u2026 PubMed that utilized oncolytic viruses. Trials were reviewed for type of oncolytic virus used, \u2026"
    },
    {
        "title": "Oncolytic virus therapy: A new era of cancer treatment at dawn",
        "link": "https://onlinelibrary.wiley.com/doi/abs/10.1111/cas.13027",
        "authors": "H Fukuhara, Y Ino, T Todo\u00a0- Cancer science, 2016 - Wiley Online Library",
        "abstract": "\u2026 Oncolytic virus therapy has recently been recognized as a promising new therapeutic \u2026 \nAn oncolytic virus is defined as a genetically engineered or naturally occurring virus that can \u2026"
    }
]